Quach, H., Parmar, G., Ocio San Miguel, E. M., Prince, H. M., Oriol, A., Crowther, H., . . . Moreau, P. (2024). A multi-center, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma.
Citación estilo ChicagoQuach, Hang, et al. A Multi-center, Phase Ib Study of Subcutaneous Administration of Isatuximab in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed/refractory Multiple Myeloma. 2024.
Cita MLAQuach, Hang, et al. A Multi-center, Phase Ib Study of Subcutaneous Administration of Isatuximab in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed/refractory Multiple Myeloma. 2024.
Precaución: Estas citas no son 100% exactas.